SCHEMBL20161842

SCHEMBL20161842

CC[C@@H]1CNCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2462390 1.00
SCHEMBL24106664 0.95 CXCR4 (0.39)
SCHEMBL336970 0.85
SCHEMBL336761 0.85
SCHEMBL294661 0.85
Bromide SCHEMBL2466273 0.83 LTA4H (0.34)
SCHEMBL4442861 0.83 CXCR4 (0.36)
Ammonia Solution, Strong SCHEMBL28170485 0.83
Hydrochloric Acid SCHEMBL4037736 0.83 LTA4H (0.34)
Hydrochloric Acid SCHEMBL4684318 0.83 LTA4H (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089261-A2 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed